Investors better get ready for a busy week ahead.
News & Analysis: Alnylam Pharmaceuticals
The biotech could go from one to four marketed drugs in a little over a year.
ALNY earnings call for the period ending June 30, 2019.
Additional drug approvals and launches are on the way.
Investors are starting to wonder if there's anything that can lift this stock higher.
ALNY earnings call for the period ending March 31, 2019.
Everything's falling into place for the pioneer of RNA interference.
Here's what you need to know about two biotechs that will present trial results that could send their stock prices soaring -- or plummeting.
The biotech has launched its first drug, Onpattro, but don't forget about its pipeline of drugs to come.
ALNY earnings call for the period ending December 31, 2018.